Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. - Wikidata - wikimedia - TriplyDB

Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses.

Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses.

http://www.wikidata.org/entity/Q33882901

about

Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis Rapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cells Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial Recent insights into the cellular biology of atherosclerosis Statin use in giant cell arteritis: a retrospective study.KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production.Role of Kruppel-like factors in leukocyte development, function, and disease HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells.Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease.Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis.Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis.Effects of statins on cardiorenal syndrome.Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy Peripheral tolerance can be modified by altering KLF2-regulated Treg migration Simvastatin protects ischemic spinal cord injury from cell death and cytotoxicity through decreasing oxidative stress: in vitro primary cultured rat spinal cord model under oxygen and glucose deprivation-reoxygenation conditions Soy-Leaf Extract Exerts Atheroprotective Effects via Modulation of Krüppel-Like Factor 2 and Adhesion Molecules Kruppel-like factors and vascular inflammation: implications for atherosclerosis.Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase increases the expression of interferon-responsive genes.Pleiotropic Effects of Statins on the Cardiovascular System.Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses.Statins as anti-inflammatory therapy in HIV disease?What is a relevant statin concentration in cell experiments claiming pleiotropic effects?Statin Modulation of Human T-Cell Proliferation, IL-1β and IL-17 Production, and IFN-γ T Cell Expression: Synergy with Conventional Immunosuppressive Agents.Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors.Pretreatment Donors after Circulatory Death with Simvastatin Alleviates Liver Ischemia Reperfusion Injury through a KLF2-Dependent Mechanism in Rat.Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential.A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).

P2860

Q26852339-87B87CBE-46BC-48A1-8424-72B4AB4CB6CA Q28482627-76E20404-E602-4A8E-BBF1-AB384A749B7C Q28731029-E3A9E934-6558-4B83-A98C-F214E2B6B6F4 Q28742007-FF7D14FF-2566-4129-9BA9-80B1329EA86D Q30300194-2CC6E737-A70F-49C3-ABE4-19D37130F0B3 Q33576127-242E6439-8006-43D9-9FB3-B45C2977FDCA Q33853966-ED0183DA-DBEE-4ADB-B9D1-AB9BBEA2EAC5 Q34374035-7691700F-7E5F-410F-B3F5-2F44407746F7 Q34494208-C350409D-73C5-4337-9151-2614348353D0 Q35025500-8DE60B7E-EB22-4A87-9D31-8D0D62D552BC Q35035564-B332D138-4632-4007-8578-09613AF398D0 Q35102167-FEC46D78-9464-4C8A-B630-1CAA3753AB1F Q35208359-6D745CD0-B1E2-472B-9268-D12D366D67B0 Q35810049-21EA9BB9-D325-4653-9701-FC212329F5C6 Q36005139-E9892D1E-24B9-4FB7-8334-B6BD9CE29E4E Q36041802-83544CD0-CE88-46FB-BF3C-12A36C7E827B Q36077149-7119F496-F9B8-4815-9D40-F8515BEF2F69 Q36610349-0C0AC7AB-8F6C-4AC6-830B-D82EA0F00459 Q36611305-0A27E10C-36AD-4ED8-B3CF-564FE182B644 Q37181861-4AE88235-9876-4409-B23E-9C38F79D3E8E Q37671313-6C1F833F-98C2-4E96-9097-3D647562092D Q37690902-000F522A-2092-4113-B7C9-7406D45AC127 Q38031130-30FD44D3-9DBB-40AF-B6E6-2E8A9CB45425 Q38966882-7FC91235-7477-4B79-AB67-DC5BA5E1BD28 Q39069187-EED46887-3DC8-4165-914C-47DF420F3404 Q39193752-67BAE966-1B65-4131-8BBF-6ECC867CC396 Q42710665-9523A289-7F72-4B35-B697-19B21E76F1C0 Q42836431-1AE04277-0605-4228-941A-BE28C1679655 Q42958893-2FABDC1F-5D88-4564-B029-4619BB369A86 Q47754842-59EA34B2-9572-4DF5-8BDC-852F2BE26EC1 Q48214383-8DD14861-98CD-4179-9005-BA2406CDF70A Q49828837-CE4E4797-15A6-4263-8481-BBC974AE7EAC Q53175089-3E869240-C3D0-4DC8-92CD-A415496FD7D5

P2860

Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses.

http://www.wikidata.org/entity/Q33882901

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@ast

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@en

type

label

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@ast

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@en

prefLabel

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@ast

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@en

P1433

Q33882901-736B6FA8-57D6-4178-B8A1-71B92B5E0F12

P1476

Q33882901-6FD1E437-3667-4B47-AB3C-B2F83115DD37

P2093

Q33882901-045399B6-02AD-4CAA-8BA3-D4FBB4A83959

Q33882901-05D28632-41DE-45B7-AFA7-349F88598702

Q33882901-07EF2842-8F87-4CB1-9159-EF0916943C2D

Q33882901-18EF7721-0DE6-4335-9C4C-F582FF436C86

Q33882901-2F37E673-3326-4185-B88E-F36790FDA0F1

Q33882901-54F0BF85-C95B-4974-A4E5-DA5D085C5F67

Q33882901-706D643B-E061-40C4-ACEB-813ADE5F4BE9

Q33882901-9C00E90A-514D-40FE-BABB-CB57A0D29A36

Q33882901-D735FB04-8AE6-44BD-A2F7-52651D5A0112

Q33882901-ED81D308-917F-4B34-9347-2229299294AA

P2860

Q33882901-0D95A27E-3E07-4A91-85B4-4BE40C5FA3A2

Q33882901-0F50782B-E6DC-43FD-B86E-D978BCB6F36A

Q33882901-0F5695C5-1B35-4577-90ED-80CE79812D9C

Q33882901-162DC643-B65A-4C71-A8D1-D0232A14B5F2

Q33882901-215BFC44-CC54-4910-96F7-FFCC3C9B56F0

Q33882901-2E74A68E-3C4B-44D9-8D61-45E61D86BE6E

Q33882901-3BA56387-9243-4942-ACEA-64C22FC04CD1

Q33882901-3DEF5F54-7BAD-451A-8E46-3C421A33E261

Q33882901-3E2D7BD8-9BBF-4BAE-BA3C-487591E5A744

Q33882901-3EF76C03-A440-41DB-94A5-638B904E545B

P304

Q33882901-0E623C53-0048-49BE-8A33-E32D0F92944E

P31

Q33882901-3FA291AF-8CCB-487A-BCF4-14B37615C012

P356

Q33882901-8E076AD0-7F0E-4915-AA07-D26042CA23BB

P407

Q33882901-DE8A8460-A87B-4194-A192-C8E5548F094D

P433

Q33882901-B60B216B-40A2-42D7-8D74-4ADC8F5DA7AF

P478

Q33882901-16AE83F4-CAE0-40D2-904A-25DB7AC72BB4

P577

Q33882901-3667AA58-B60A-4428-B78D-9A0E6365B3A2

P5875

Q33882901-72904454-3627-4DE2-B79D-3BE68BAD0632

P698

Q33882901-6C13B4B3-A808-4F81-ADE2-D18F595FBA63

P932

Q33882901-331D3D05-C8DA-4BA6-82AB-D8BABF8A3C04

P356

P1433

Journal of Clinical Investigation

P1476

Statin-induced Krüppel-like fa ...... tory and pathogenic responses.

@en

P2093

Andrew H Lichtman

http://www.w3.org/2001/XMLSchema#string

De-xiu Bu

http://www.w3.org/2001/XMLSchema#string

Elena Maganto-Garcia

http://www.w3.org/2001/XMLSchema#string

George Stavrakis

http://www.w3.org/2001/XMLSchema#string

Guillermo García-Cardeña

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yamazaki

http://www.w3.org/2001/XMLSchema#string

Margarite Tarrio

http://www.w3.org/2001/XMLSchema#string

Masanori Aikawa

http://www.w3.org/2001/XMLSchema#string

Nir Grabie

http://www.w3.org/2001/XMLSchema#string

Petr Jarolim

http://www.w3.org/2001/XMLSchema#string

P2860

The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Kruppel-like factor 2 regulates thymocyte and T-cell migration

Role of Krüppel-like transcription factors in endothelial biology

Locking a leukocyte integrin with statins.

Location is everything: lipid rafts and immune cell signaling.

Neutrophils sustain pathogenic CD8+ T cell responses in the heart.

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

Toward immunomodulatory and anti-inflammatory properties of statins.

Biomechanical modulation of endothelial phenotype: implications for health and disease.

P304

1961-1970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI41384

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44570971

http://www.w3.org/2001/XMLSchema#string

P698

20440076

http://www.w3.org/2001/XMLSchema#string

P932

2877947

http://www.w3.org/2001/XMLSchema#string